Nanoform, a nanoparticle medicine enabling company, and Orion Corp., a pharmaceutical company, have entered a collaboration to apply Nanoform’s CESS technology to new chemical entities to improve the bioavailability and solubility of selected early-development compounds, increasing the likelihood of drugs entering clinical development. Many new chemical entities struggle to progress into clinical development due to their physico-chemical properties and respective solubility and bioavail...